Non-Hodgkin's lymphoma in patients 80 years of age or older

Annals of Oncology : Official Journal of the European Society for Medical Oncology
O BaireyR Ruchlemer

Abstract

Very elderly patients (> or =80 years old) with non-Hodgkin's lymphoma (NHL) frequently have co-morbid conditions and are generally excluded from clinical trials or even from treatment. The optimal treatment of these patients is unknown. We reviewed the records of 109 patients > or =80 years at diagnosis of NHL (65 F/44 M; median age: 84 years, range; 80-95). Seventy-eight patients (72%) had aggressive NHL, 25 (23%) had indolent and NHL, eight had unclassified disease. Advanced-stage disease was noted in 54%. Forty patients (39%) had a poor ECOG performance status (PS), and 52 (49%) had an intermediate or high risk International Prognostic Index (IPI). Seventy-nine patients (72%) were treated with chemotherapy and 37 (34%) with radiotherapy. Initial chemotherapy consisted of chlorambucil in 15, oral etoposide in 2, and combination protocol in 62. Only 16% of patients received full-dose therapy, and only 50% completed > or =6 cycles of combination chemotherapy. The overall response rate for the 69 evaluable patients was 84% (complete 56.5%, partial 27.5%). Overall 5-year survival for the whole group was 39%, and median survival time was 26 months. A high response rate can be achieved in very elderly NHL patients despite aggressi...Continue Reading

References

Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseJ Mailliard
Dec 1, 1987·The American Journal of Medicine·P Solal-CelignyP Boivin
Mar 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D O DixonH E Wilson
Apr 1, 1984·Journal of the American Geriatrics Society·J O Armitage, J F Potter
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H GómezC Vallejos
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 28, 2004·Seminars in Oncology·Arati V RaoHarvey Jay Cohen
Apr 28, 2004·Seminars in Oncology·Eric H Westin, Dan L Longo
Apr 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MonfardiniV Torri

❮ Previous
Next ❯

Citations

May 27, 2011·Annals of Hematology·Osnat BaireyUNKNOWN Israeli CLL Study Group (ICLLSG)
Aug 19, 2008·Current Oncology Reports·Pieternella J Lugtenburg, Pieter Sonneveld
Sep 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A M van de SchansM L G Janssen-Heijnen
Aug 24, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A TrebouetR Houot
May 13, 2014·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Matthias TroeltzschSven Otto
Jun 30, 2007·Cancer Biotherapy & Radiopharmaceuticals·Agustin AvilésMargarita Contreras
Oct 16, 2015·International Journal of Clinical Oncology·Futoshi IiokaHitoshi Ohno
Aug 4, 2016·Annals of Hematology·Kamel LaribiAlix Baugier de Materre
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine Thieblemont, Bertrand Coiffier
Jul 27, 2010·The American Journal on Addictions·Angela M RobertsonSteffanie A Strathdee
Jan 27, 2011·World Journal of Gastrointestinal Oncology·Goran Z StanojevicMilan D Radojkovic
Oct 31, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Elles M ScreeverJavid J Moslehi
Jan 23, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clémentine Sarkozy, Bertrand Coiffier
May 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A M van de SchansM L G Janssen-Heijnen

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.